Krishna Mohan Vadrevu

2.1k total citations
16 papers, 251 citations indexed

About

Krishna Mohan Vadrevu is a scholar working on Infectious Diseases, Hepatology and Health. According to data from OpenAlex, Krishna Mohan Vadrevu has authored 16 papers receiving a total of 251 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 5 papers in Hepatology and 3 papers in Health. Recurrent topics in Krishna Mohan Vadrevu's work include Viral gastroenteritis research and epidemiology (9 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Hepatitis Viruses Studies and Epidemiology (5 papers). Krishna Mohan Vadrevu is often cited by papers focused on Viral gastroenteritis research and epidemiology (9 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Hepatitis Viruses Studies and Epidemiology (5 papers). Krishna Mohan Vadrevu collaborates with scholars based in India, United States and Sweden. Krishna Mohan Vadrevu's co-authors include Raches Ella, Pragya D. Yadav, Priya Abraham, Gajanan Sapkal, Gururaj Deshpande, Nivedita Gupta, Balram Bhargava, Samiran Panda, Sai Prasad and Rima R. Sahay and has published in prestigious journals such as Scientific Reports, The Journal of Infectious Diseases and Frontiers in Immunology.

In The Last Decade

Krishna Mohan Vadrevu

14 papers receiving 235 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Krishna Mohan Vadrevu India	9	222	73	29	28	24	16	251
Raches Ella India	11	313 1.4×	104 1.4×	56 1.9×	32 1.1×	22 0.9×	14	349
Mia Kontio Finland	6	120 0.5×	83 1.1×	9 0.3×	12 0.4×	18 0.8×	11	247
Josep Álvarez Spain	11	123 0.6×	40 0.5×	27 0.9×	8 0.3×	16 0.7×	28	311
Simona Zipursky United States	11	227 1.0×	89 1.2×	26 0.9×	10 0.4×	8 0.3×	19	344
Adedayo Omotayo Faneye Nigeria	9	95 0.4×	16 0.2×	13 0.4×	22 0.8×	7 0.3×	37	203
Diane Waku‐Kouomou United States	13	157 0.7×	55 0.8×	19 0.7×	41 1.5×	3 0.1×	24	292
Noortje van Maarseveen Netherlands	6	186 0.8×	33 0.5×	38 1.3×	15 0.5×	3 0.1×	7	254
Anastasia S. Lambrou United States	9	153 0.7×	47 0.6×	15 0.5×	17 0.6×	9 0.4×	16	230
Marjahan Akhtar Bangladesh	9	145 0.7×	13 0.2×	35 1.2×	3 0.1×	20 0.8×	16	247
Sultan Alqasrawi Jordan	5	358 1.6×	17 0.2×	14 0.5×	69 2.5×	4 0.2×	8	412

Countries citing papers authored by Krishna Mohan Vadrevu

Since Specialization

Citations

This map shows the geographic impact of Krishna Mohan Vadrevu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krishna Mohan Vadrevu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krishna Mohan Vadrevu more than expected).

Fields of papers citing papers by Krishna Mohan Vadrevu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krishna Mohan Vadrevu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krishna Mohan Vadrevu. The network helps show where Krishna Mohan Vadrevu may publish in the future.

Co-authorship network of co-authors of Krishna Mohan Vadrevu

This figure shows the co-authorship network connecting the top 25 collaborators of Krishna Mohan Vadrevu. A scholar is included among the top collaborators of Krishna Mohan Vadrevu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krishna Mohan Vadrevu. Krishna Mohan Vadrevu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Bhate, Amit Suresh, et al.. (2025). Effect of heterologous intranasal iNCOVACC® vaccination as a booster to two-dose intramuscular Covid-19 vaccination series: a randomized phase 3 clinical trial. Communications Medicine. 5(1). 133–133. 1 indexed citations

Vadrevu, Krishna Mohan, Amit Kumar Chawla, Bharath Chakravarthy, et al.. (2025). A double-blind, randomised phase III clinical trial to evaluate safety, immunogenicity, non-inferiority & lot to lot consistency of single component oral cholera vaccine BBV131 (Hillchol®) in comparison to Shanchol™. Vaccine. 55. 126998–126998.

Vadrevu, Krishna Mohan, et al.. (2025). Comparative immune response of Typbar TCV® (typhoid conjugate vaccine) in extremes of age: An Indian experience. Human Vaccines & Immunotherapeutics. 21(1). 2507912–2507912.

Vadrevu, Krishna Mohan. (2023). Overstated conclusions of a non-inferiority trial testing immunogenicity and safety of homologous and heterologous booster vaccination. The Lancet Regional Health - Southeast Asia. 12. 100198–100198. 1 indexed citations

Vadrevu, Krishna Mohan, et al.. (2022). Safety, immunogenicity and non-interference of concomitant Typhoid Vi capsular polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV®) and measles or measles-mumps-rubella vaccines in 8–9 months-old Indian children. Human Vaccines & Immunotherapeutics. 18(7). 2150030–2150030. 5 indexed citations

Vadrevu, Krishna Mohan, Brunda Ganneru, Siddharth Reddy, et al.. (2022). Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants. Scientific Reports. 12(1). 12038–12038. 22 indexed citations

Sunagar, Raju, Sai Prasad, Raches Ella, & Krishna Mohan Vadrevu. (2022). Preclinical evaluation of safety and immunogenicity of a primary series intranasal COVID-19 vaccine candidate (BBV154) and humoral immunogenicity evaluation of a heterologous prime-boost strategy with COVAXIN (BBV152). Frontiers in Immunology. 13. 1063679–1063679. 24 indexed citations

Yadav, Pragya D., Sreelekshmy Mohandas, Anita M. Shete, et al.. (2022). Protective efficacy of COVAXIN® against Delta and Omicron variants in hamster model. iScience. 25(10). 105178–105178. 5 indexed citations

Vadrevu, Krishna Mohan, Siddharth Reddy, Harsh Jogdand, et al.. (2022). Immunogenicity and reactogenicity of an inactivated SARS-CoV-2 vaccine (BBV152) in children aged 2–18 years: interim data from an open-label, non-randomised, age de-escalation phase 2/3 study. The Lancet Infectious Diseases. 22(9). 1303–1312. 21 indexed citations

10.

Deshpande, Gururaj, Pragya D. Yadav, Priya Abraham, et al.. (2022). Booster dose of the inactivated COVID-19 vaccine BBV152 (Covaxin) enhances the neutralizing antibody response against Alpha, Beta, Delta and Omicron variants of concern. Journal of Travel Medicine. 29(3). 21 indexed citations

11.

Vadrevu, Krishna Mohan, Sandhya Rani, Siddharth Reddy, et al.. (2021). Persisting antibody responses to Vi polysaccharide–tetanus toxoid conjugate (Typbar TCV®) vaccine up to 7 years following primary vaccination of children < 2 years of age with, or without, a booster vaccination. Vaccine. 39(45). 6682–6690. 24 indexed citations

12.

Sapkal, Gajanan, Pragya D. Yadav, Raches Ella, et al.. (2021). Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2. Journal of Travel Medicine. 28(4). 85 indexed citations

13.

Sarangi, Vamshi, et al.. (2021). A multi-centre, post-marketing surveillance study of Vi polysaccharide–tetanus toxoid conjugate vaccine (Typbar TCV®) in India. Human Vaccines & Immunotherapeutics. 18(1). 1947761–1947761. 2 indexed citations

14.

Ella, Raches, Sudhir Babji, Max Ciarlet, William C. Blackwelder, & Krishna Mohan Vadrevu. (2019). A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC® in comparison with a licensed rotavirus vaccine in healthy infants. Vaccine. 37(31). 4407–4413. 12 indexed citations

15.

Vadrevu, Krishna Mohan, et al.. (2019). Persistence of Immune Responses With an Inactivated Japanese Encephalitis Single-Dose Vaccine, JENVAC and Interchangeability With a Live-Attenuated Vaccine. The Journal of Infectious Diseases. 222(9). 1478–1487. 14 indexed citations

16.

Ella, Raches, et al.. (2018). A Phase 4, multicentre, randomized, single-blind clinical trial to evaluate the immunogenicity of the live, attenuated, oral rotavirus vaccine (116E), ROTAVAC®, administered simultaneously with or without the buffering agent in healthy infants in India. Human Vaccines & Immunotherapeutics. 14(7). 1791–1799. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact